ATM and non-small cell lung carcinoma: In radiotherapy for non-small cell lung cancer (NSCLC), DNA damage repair of tumor cells occurs through the MRN-SERPINE2-ATM-RAD51 pathway, resulting in radioresistance, leading to NSCLC radiotherapy failure (Hou et al., 2019).